content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001838112</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001607678</issuerCik>
        <issuerName>Viking Therapeutics, Inc.</issuerName>
        <secFileNumber>001-37355</secFileNumber>
        <issuerAddress>
          <com:street1>9920 PACIFIC HEIGHTS BLVD, SUITE 350</com:street1>
          <com:city>SAN DIEGO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>858-704-4660</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Mancini Marianna</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Oppenheimer &amp; Co Inc</name>
          <address>
            <com:street1>85 Broad Street</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10004</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>281425</noOfUnitsSold>
        <aggregateMarketValue>78.65</aggregateMarketValue>
        <noOfUnitsOutstanding>110268210</noOfUnitsOutstanding>
        <approxSaleDate>05/01/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>01/03/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Stock option Grant</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>35426</amountOfSecuritiesAcquired>
        <paymentDate>05/01/2024</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>03/31/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Option Grant</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>17999</amountOfSecuritiesAcquired>
        <paymentDate>05/01/2024</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>01/04/2021</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Option Grant</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>90000</amountOfSecuritiesAcquired>
        <paymentDate>05/01/2024</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>01/03/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Option Grant</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>87000</amountOfSecuritiesAcquired>
        <paymentDate>05/01/2024</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>01/31/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Option Grant</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>51000</amountOfSecuritiesAcquired>
        <paymentDate>05/01/2024</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>selling pursuant to 10b5-1 trading plan dated 2/1/2024 - POA on file</remarks>
      <noticeSignature>
        <noticeDate>05/01/2024</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>02/01/2024</planAdoptionDate>
        </planAdoptionDates>
        <signature>Marianna Mancini</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 5016}]
text: 144
  0001838112
  XXXXXXXX
  LIVE
  0001607678
  Viking Therapeutics, Inc.
  001-37355
  9920 PACIFIC HEIGHTS BLVD, SUITE 350
  SAN DIEGO
  CA
  92121
  858-704-4660
  Mancini Marianna
  Officer
  common
  Oppenheimer & Co Inc
  85 Broad Street
  New York
  NY
  10004
  281425
  78.65
  110268210
  05/01/2024
  NASDAQ
  common
  01/03/2020
  Stock option Grant
  Issuer
  N
  35426
  05/01/2024
  N/A
  common
  03/31/2020
  Stock Option Grant
  Issuer
  N
  17999
  05/01/2024
  N/A
  common
  01/04/2021
  Stock Option Grant
  Issuer
  N
  90000
  05/01/2024
  N/A
  common
  01/03/2022
  Stock Option Grant
  Issuer
  N
  87000
  05/01/2024
  N/A
  common
  01/31/2023
  Stock Option Grant
  Issuer
  N
  51000
  05/01/2024
  N/A
  Y
  selling pursuant to 10b5-1 trading plan dated 2/1/2024 - POA on file
  05/01/2024
  02/01/2024
  Marianna Mancini